• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-09-11

  This scenario-based guide explains how ECL Chemiluminescent Substrate Detection Kit, SKU K1129, supports HRP-based Western blot and chemiluminescent immunoassay workflows that complement cell viability, proliferation, and cytotoxicity studies. It covers reaction principles, protocol parameters, data interpretation, and practical vendor-selection criteria.

• Solanesol B8776: Practical Workflow Guide

  2026-09-11

  Solanesol (B8776) is a hydrophobic polyisoprenoid alcohol for controlled biochemical, pharmaceutical, and membrane-related research workflows. This guide covers DMSO stock preparation, storage, QC, and assay controls, while clarifying that the material is insoluble in water and ethanol and is not intended for diagnostic or medical use.

• Carvedilol Phosphate in Hepatic IRI Models

  2026-09-10

  Carvedilol Phosphate gives researchers a controllable non-selective beta blocker perturbation for connecting GPCR signaling with hepatocyte stress and macrophage responses. This guide translates recent Arrb2–6-ketoLCA findings into formulation, ischemia–reperfusion injury model, assay-design, and troubleshooting strategies without overstating the evidence.

• EZ Cap Cy5 Firefly Luciferase mRNA: Assay Logic

  2026-09-10

  EZ Cap Cy5 Firefly Luciferase mRNA combines Cy5-based delivery tracking with luciferase-based functional expression. This article presents a decision-oriented assay framework linking reporter readouts to LNP design, translation efficiency, and findings from recent ocular genome-editing research.

• Abiraterone acetate in 3D Prostate Models

  2026-09-09

  Build a formulation-aware workflow for testing a CYP17 inhibitor in patient-derived prostate spheroids, from tissue processing through androgen-response readouts. The approach distinguishes target engagement from 3D delivery limits and helps explain why organ-confined models may respond differently from conventional cell lines.

• Hematoxylin and Eosin Staining: K1142 Guide

  2026-09-09

  The Hematoxylin and Eosin staining workflow uses complementary dyes to visualize nuclei, cytoplasm, extracellular matrix, and tissue architecture. The H&E staining kit K1142 supplies ready-to-use solutions for research workflows involving paraffin-embedded sections, frozen sections, and cytological preparations.

• ARCA Cy5 EGFP mRNA: Assay Design Guide

  2026-09-08

  ARCA Cy5 EGFP mRNA (5-moUTP) enables a practical framework for separating cellular uptake from productive translation. Learn how to design rigorous delivery assays and apply insights from biodegradable polyester nanoparticles for ischemia research.

• CK2 Phosphorylation Tunes Plant Ceramide Synthase

  2026-09-08

  The reference study shows that CK2 phosphorylation regulates Arabidopsis LOH2 at two C-terminal serines, increasing catalytic activity while accelerating polyubiquitination and proteasomal turnover. This dual control links ceramide production with salicylic acid accumulation, cell death, and resistance to fungal and bacterial challenges.

• B7H3×CD3 BiTE mRNA-LNPs in Solid and Blood Cancers

  2026-09-07

  The reference study developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. Its central finding was that one intravenous administration produced substantial in vivo BiTE expression, extended exposure, and durable antitumor activity in models of hematologic malignancy and melanoma.

• PSMD14–CARM1 Axis in Hepatocellular Carcinoma

  2026-09-07

  This study identifies PSMD14-mediated deubiquitination as a mechanism that elevates CARM1 in hepatocellular carcinoma and connects CARM1 activity to FERMT1 transcription through H3R17 dimethylation. The findings define a PSMD14–CARM1–FERMT1 pathway that promotes tumor growth and metastasis and provide pharmacological support for targeting CARM1.

• Reserpine N1867: Practical Lab Workflow Guide

  2026-09-05

  Reserpine (SKU N1867) provides a defined research reagent for neurotransmitter depletion, antihypertensive mechanism, and neuropharmacology workflows where controlled solubilization and fresh-solution handling are important. It is intended for laboratory research only, not for diagnostic, therapeutic, medical, or veterinary use.

• Tomivosertib: From eIF4E Signal to Assay Design

  2026-09-04

  Tomivosertib is a potent MNK1 inhibitor for resolving how MNK-dependent eIF4E phosphorylation connects tumor-cell survival with glioblastoma angiogenesis. This guide translates the key glioblastoma evidence into practical model-selection, control, and assay-interpretation strategies.

• Naftifine HCl: Designing Better Antifungal Assays

  2026-09-04

  Naftifine HCl is an allylamine antifungal agent whose value extends beyond routine growth inhibition assays. This guide explains how to connect sterol-pathway biology, orthogonal readouts, solvent control, and lessons from multidimensional muscle-cell research to build more interpretable antifungal experiments.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-03

  Chen et al. identified circulating moesin as a marker associated with endothelial injury and sepsis severity, linking serum levels to SOFA scores, procalcitonin, and experimental lung damage. The study also connects moesin to ROCK1/MLC and NF-κB signaling in endothelial cells, providing a mechanistic basis for future biomarker and vascular-barrier research.

• Moxidectin for Antifungal Synergy Research

  2026-09-03

  Moxidectin is an established veterinary antiparasitic now being evaluated as an ergosterol-directed potentiator for polyene antifungal research. This guide translates the finding into practical workflows for Candida growth, biofilm, mechanism, and preclinical validation assays while separating evidence-backed observations from assay-development recommendations.

8075 records 1/539 page Next 12345 下5页 Last page